Video

Q&A With David Bernstein From the University of Cincinnati: Sublingual Allergy Treatment Provides Alternative To Shots

Author(s):

For patients with severe seasonal allergies the regularly available medications may not be enough to help their symptoms while the prospect of shots may be prohibitive enough to keep them from getting shots. A newly approved treatment could provide an alternative to the needle.

For patients with severe seasonal allergies the regularly available medications may not be enough to help their symptoms while the prospect of shots may be prohibitive enough to keep them from getting shots. A newly approved treatment could provide an alternative to the needle.

David Bernstein, MD, from the University of Cincinnati discussed what this new treatment method could mean to patients and healthcare providers during the American College of Allergy, Asthma, and Immunology's annual meeting in San Antonio.

Related Videos
Enhancing Standards for Ethical Responsibilities within Clinical Research
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.